ReShape Lifesciences Inc.
Hedge Funds Holdings
Last updated:
ReShape Lifesciences Inc.‘s stocks are currently a part of 7 hedge funds’ portfolios, which represents 8.42% of the total amount of its stocks outstanding. This makes up a total of 35.75K shares of ReShape Lifesciences Inc.. Compared to the previous quarter, the number grew by 2025.56% or 34.07K shares more. As for the holding position changes, 28.57% (2) of current hedge fund investors increased the number of shares held, 14.29% (1) of current holders sold a part of the shares held. 2 hedge funds are new holders of ReShape Lifesciences Inc. stock in Q1 2023, it is 28.57% of total holders.
Hedge funds holding ReShape Lifesciences (Q2 2018 – Q1 2023)
| Q2 2018 | 10 |
|---|---|
| Q3 2018 | 9 |
| Q4 2018 | 1 |
| Q1 2019 | 0 |
| Q2 2019 | 1 |
| Q3 2019 | 18 |
| Q4 2019 | 13 |
| Q1 2020 | 12 |
| Q2 2020 | 8 |
| Q3 2020 | 10 |
| Q4 2020 | 13 |
| Q1 2021 | 13 |
| Q2 2021 | 10 |
| Q3 2021 | 15 |
| Q4 2021 | 13 |
| Q1 2022 | 14 |
| Q2 2022 | 15 |
| Q3 2022 | 17 |
| Q4 2022 | 8 |
| Q1 2023 | 7 |
Hedge funds changes in ReShape Lifesciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 9 | 0 | 1 | 13 | -13 |
|---|---|---|---|---|---|
| Q3 2018 | 5 | 3 | 1 | 6 | -6 |
| Q4 2018 | 0 | 1 | 0 | 8 | -8 |
| Q1 2019 | 0 | 0 | 0 | 1 | -1 |
| Q2 2019 | 1 | 0 | 0 | 0 | 0 |
| Q3 2019 | 18 | 0 | 0 | 1 | -1 |
| Q4 2019 | 3 | 1 | 5 | 8 | -4 |
| Q1 2020 | 5 | 1 | 2 | 5 | -1 |
| Q2 2020 | 2 | 1 | 1 | 6 | -2 |
| Q3 2020 | 2 | 2 | 1 | 1 | 4 |
| Q4 2020 | 6 | 3 | 1 | 3 | 0 |
| Q1 2021 | 2 | 4 | 1 | 2 | 4 |
| Q2 2021 | 10 | 0 | 0 | 13 | -13 |
| Q3 2021 | 11 | 3 | 1 | 6 | -6 |
| Q4 2021 | 4 | 5 | 2 | 5 | -3 |
| Q1 2022 | 4 | 2 | 3 | 3 | 2 |
| Q2 2022 | 4 | 3 | 2 | 2 | 4 |
| Q3 2022 | 5 | 4 | 4 | 4 | 0 |
| Q4 2022 | 8 | 0 | 0 | 17 | -17 |
| Q1 2023 | 2 | 2 | 1 | 0 | 2 |
Hedge funds changes in ReShape Lifesciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 11,000 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |
Top 50 hedge fund holders of ReShape Lifesciences Inc. (NASDAQ:RSLS)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 92K | 306.61K | 0.000% |
| VANGUARD GROUP INC | 36K | 118.60K | 0.000% |
| JANE STREET GROUP, LLC | 16K | 52.18K | 0.000% |
| HRT FINANCIAL LP | 16K | 55.88K | 0.000% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11K | 36.1K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 10K | 32.23K | 0.000% |
| NORTHERN TRUST CORP | 10K | 33.42K | 0.000% |
| RENAISSANCE TECHNOLOGIES LLC Jim Simons | 10K | 32.88K | 0.000% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 9K | 30.2K | 0.000% |
| TWO SIGMA SECURITIES, LLC | 6K | 20.29K | 0.000% |
| STATE STREET CORP | 6K | 20.7K | 0.000% |
| ERGOTELES LLC | 4K | 13.95K | 0.000% |
| GOLDMAN SACHS GROUP INC | 4K | 14.34K | 0.000% |
| VIRTU FINANCIAL LLC | 3K | 10.79K | 0.000% |
| MILLENNIUM MANAGEMENT LLC Israel Englander | 3K | 10.70K | 0.000% |
| ADVISOR GROUP HOLDINGS, INC. | 1K | 3.73K | 0.000% |
| TRANSAMERICA FINANCIAL ADVISORS, INC. | 1K | 75 | 0.000% |
| BLACKROCK INC. Larry Fink | 0 | 0 | 0.000% |
| CITADEL ADVISORS LLC Ken Griffin | 0 | 0 | 0.000% |
| UBS GROUP AG | 0 | 0 | 0.000% |
| ARMISTICE CAPITAL, LLC | 0 | 0 | 0.000% |